# Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33  Clinical Trials Not Allowed)

> Federal funding opportunity · **POSTED** · National Institutes of Health · close: **12/23/2027**

## Key facts

- **Opportunity ID:** 357334
- **Opportunity number:** RFA-HL-26-017
- **Agency:** National Institutes of Health
- **Status:** posted
- **Document type:** synopsis
- **Open date:** 11/22/2024
- **Close date:** 12/23/2027
- **CFDA codes:** 93.838, 93.233, 93.839, 93.855, 93.837

## Primary source

Grants.gov opportunity detail: https://www.grants.gov/search-results-detail/357334

## Citation

> US Grants.gov, funding opportunity 357334 (RFA-HL-26-017). Retrieved via AI Analytics 2026-05-16 from https://api.ai-analytics.org/opportunity/357334. Licensed CC0.

---

*[Grants.gov dataset](/datasets/grants-gov) · CC0 1.0*
